La Barbera et al., 2021, reported that nilotinib reduced c-Abl phosphorylation and Aβ levels as well and prevented the degeneration of dopaminergic neurons in the Tg2576 murine model of AD [35]. This evidence concerns the gene ABL1 and Alzheimer disease.